REGULATORY
JPMA Official Calls for Partial Introduction of CDISC-Based Electronic Applications; Runup Period too Short
Masaaki Kuwahara (Senior Director, Regulatory Affairs Department, Development Center Japan, Pharmaceutical Development Division, Takeda Pharmaceutical), chairman of the Japan Pharmaceutical Manufacturers Association’s (JPMA) Regulatory Affairs Committee, spoke on the electronic applications that will become mandatory from FY2016 at a symposium…
To read the full story
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- New Digital Minister Furukawa Pledges Push for Healthy Longevity
September 24, 2026
- MHLW Eyes Higher Long-Term Care Premiums for Wealthier Seniors
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





